Level Biotechnology Working Capital to Net Assets Ratio
Level Biotechnology working capital to net assets ratio. Level Biotechnology (3118) has a Working Capital to Net Assets ratio of 37.4% as of September 2025. Working capital of NT$210.42 Million (current assets of NT$436.15 Million minus current liabilities of NT$225.72 Million) is measured against net assets of NT$562.82 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 3118 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Level Biotechnology (2017–2024)
Working capital to net assets ratio of Level Biotechnology from 2017 to 2024. This chart shows how Level Biotechnology's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 37.4%, reflecting working capital of NT$210.42 Million against net assets of NT$562.82 Million TWD. See Level Biotechnology defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Level Biotechnology Working Capital to Net Assets Ratio by Year (2017–2024)
Level Biotechnology working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Level Biotechnology from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Level Biotechnology.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 41.3% | NT$231.46 Million | NT$559.91 Million | NT$483.95 Million | NT$252.49 Million | ▼ -36.5 pp |
| 2023 | 77.8% | NT$427.74 Million | NT$549.47 Million | NT$680.50 Million | NT$252.76 Million | ▲ +2.0 pp |
| 2022 | 75.8% | NT$411.22 Million | NT$542.40 Million | NT$665.82 Million | NT$254.59 Million | ▲ +0.7 pp |
| 2021 | 75.1% | NT$409.06 Million | NT$544.84 Million | NT$634.24 Million | NT$225.17 Million | ▲ +2.6 pp |
| 2020 | 72.5% | NT$383.95 Million | NT$529.43 Million | NT$608.50 Million | NT$224.55 Million | ▲ +3.8 pp |
| 2019 | 68.7% | NT$353.06 Million | NT$513.75 Million | NT$568.79 Million | NT$215.73 Million | ▲ +3.6 pp |
| 2018 | 65.1% | NT$324.85 Million | NT$498.78 Million | NT$500.63 Million | NT$175.78 Million | ▼ -0.2 pp |
| 2017 | 65.3% | NT$341.27 Million | NT$522.28 Million | NT$546.09 Million | NT$204.82 Million | — |